Business
JP Morgan initiates coverage of Telix Pharmaceuticals. After rising 1,667% in 5 years, is it still a buy?
Image source: Getty Images
Telix Pharmaceuticals Ltd (ASX: TLX) shares have been a standout performer over the past 5 years.
The ASX 200 radiopharmaceutical company has soared a staggering 1,667% over that timeframe.
Over the past year, shares are up 21%.
Early and recent investors in Telix…
Continue Reading
-
General19 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News18 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General24 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says
-
General11 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat